InvestorsHub Logo
Followers 5
Posts 475
Boards Moderated 0
Alias Born 05/07/2015

Re: None

Wednesday, 07/27/2022 1:49:01 PM

Wednesday, July 27, 2022 1:49:01 PM

Post# of 73550
Last current idea: If someone has access to FAX capability, one could try the FAX number from https://www.viadermalicensing.com/ ( 310-943-1457 ). I am posting the text of my email that could be modified for a FAX, if possible.

Below is the text of my email, mentioned in previous post:

Since you are not responding to info@viadermalicensing,com, I will try this address.

Urgent action is required from Dr Otiko or other authorized representative regarding communication with otcmarkets to get substantive otcmarkets errors corrected.

Otcmarkets ( https://www.otcmarkets.com/stock/VDRM/disclosure ) has mistakenly assumed VDRM is Accelerated Filer and thus, 2nd Qtr Report due 7/31/22. Further, otcmarkets has massively misinterpreted Rule 15c2-11:

https://www.wilmerhale.com/insights/client-alerts/20201029-sec-amends-rule-15c2-11-to-enhance-publicly-available-information-for-securities-quoted-in-the-over-the-counter-markets

Instead of applying the Grace Period after the due date is passed, they are applying it before the due date (and the wrong grace period and due date at that). They have then erroneously applied the Grace Period, and Dark or Defunct labels. These are wrong on so many levels. VDRM is Non-Accelerated Filer and thus, 2nd Quarter Report is not due until 8/15/22. The four-day Grace Period should then be applied beyond that.

I realize this is the wrong email address for this, but we shareholders do not seem to have any other means to identify this to Dr Otiko. Please pass it along, with URGENCY.

Thanks, in advance, for any and all help in the above.